Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $51.6M
Latest Deal Amount

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) General Information

Description

Neoleukin Therapeutics was a biopharmaceutical company that generated immunotherapies using de novo protein design technology. The firm used computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 401 Terry Avenue North
  • Seattle, WA 98109
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Aug-2019 $51.6M 00000 0000 Completed Generating Revenue/Not Profitable
1. Early Stage VC 08-Feb-2019 00000 00000 Completed Generating Revenue/Not Profitable
To view Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s complete valuation and funding history, request access »

Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
WRF Capital Venture Capital Minority 000 0000 000000 0
To view Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals)’s complete investors history, request access »